Specializes in gene therapy, offering process development, viral vector production, and integrated solutions for clinical applications in the biopharmaceutical industry.
Baltimore
Baltimore City
Maryland
Notice Date
November 6, 2025
January 5, 2026
Unavailable
31 Manufacturing
More WARN Notices from